Ronald B. Postuma

Ronald B. Postuma's AcademicInfluence.com Rankings

Ronald B. Postuma

Philosophy

#7453

World Rank

#10673

Historical Rank

Logic

#4501

World Rank

#5807

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Ronald B. Postuma's Degrees

Doctorate Medicine McGill University

Why Is Ronald B. Postuma Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ronald B. Postuma's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

MDS clinical diagnostic criteria for Parkinson's disease (2015) (3560)
Diagnosis and management of dementia with Lewy bodies (2017) (1606)
MDS research criteria for prodromal Parkinson's disease (2015) (897)
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder (2009) (723)
Basal ganglia functional connectivity based on a meta-analysis of 126 positron emission tomography and functional magnetic resonance imaging publications. (2006) (553)
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy (2017) (502)
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study (2019) (482)
Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease (2012) (474)
New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. (2015) (415)
Time to Redefine PD? Introductory Statement of the MDS Task Force on the Definition of Parkinson's Disease (2014) (384)
Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder (2006) (366)
Parkinson risk in idiopathic REM sleep behavior disorder (2015) (340)
Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases (2006) (339)
Neural Bases of Set-Shifting Deficits in Parkinson's Disease (2004) (327)
Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression (2017) (324)
Update of the MDS research criteria for prodromal Parkinson's disease (2019) (313)
Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease (2009) (306)
A single‐question screen for rapid eye movement sleep behavior disorder: A multicenter validation study (2012) (281)
How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. (2012) (276)
REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia (2007) (260)
Polysomnographic diagnosis of idiopathic REM sleep behavior disorder (2010) (250)
Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: A prospective study (2012) (250)
Premotor and nonmotor features of Parkinson's disease. (2014) (242)
Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease. (2009) (241)
Advances in markers of prodromal Parkinson disease (2016) (237)
Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study (2015) (232)
Research criteria for the diagnosis of prodromal dementia with Lewy bodies (2020) (232)
Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder (2011) (223)
REM sleep behaviour disorder in Parkinson’s disease is associated with specific motor features (2008) (223)
Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. (2004) (209)
Predictors of dementia in Parkinson disease (2014) (203)
Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease (2010) (197)
Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies (2013) (193)
Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. (2013) (187)
Update on the pharmacology of REM sleep behavior disorder (2006) (186)
REM sleep behaviour disorder (2018) (172)
Manifestations of Parkinson disease differ in association with REM sleep behavior disorder (2008) (169)
Tango for treatment of motor and non-motor manifestations in Parkinson's disease: a randomized control study. (2015) (168)
Caffeine for treatment of Parkinson disease (2012) (167)
Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder (2008) (167)
Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease (2012) (163)
Evaluation of smartphone‐based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial (2018) (163)
Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal? (2013) (162)
Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study. (2019) (156)
Validation of the MDS clinical diagnostic criteria for Parkinson's disease (2018) (153)
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities (2013) (144)
Prevalence and determinants of rapid eye movement sleep behavior disorder in the general population (2018) (142)
Abnormal metabolic network activity in REM sleep behavior disorder (2014) (138)
Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease -- a randomized study. (2013) (136)
Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder (2010) (130)
Assessing whole brain perfusion changes in patients with REM sleep behavior disorder (2006) (126)
Comparison of sublethal and lethal criteria for nine different chemicals in standardized toxicity tests using the earthworm Eisenia andrei. (1992) (121)
Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder (2006) (121)
REM sleep behavior disorder and neuropathology in Parkinson's disease (2015) (117)
Sleep spindles in Parkinson's disease may predict the development of dementia (2015) (113)
Validation of the non-motor symptoms questionnaire (NMS-Quest). (2012) (109)
GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder (2015) (108)
Clinical prediction of Parkinson's disease: planning for the age of neuroprotection (2010) (104)
Is there a higher risk of restless legs syndrome in peripheral neuropathy? (2009) (103)
REM sleep behavior disorder: From dreams to neurodegeneration (2012) (102)
Idiopathic REM sleep behavior disorder in the transition to degenerative disease (2009) (102)
REM Sleep Behavior Disorder and Cognitive Impairment in Parkinson's Disease (2017) (101)
Supplement 4: Canadian Guidelines on Parkinson's Disease (2012) (100)
Prodromal Parkinson disease subtypes — key to understanding heterogeneity (2021) (99)
Prodromal Parkinson's Disease: The Decade Past, the Decade to Come (2019) (97)
Movement disorder society criteria for clinically established early Parkinson's disease (2018) (96)
Subtypes of Parkinson’s Disease: What Do They Tell Us About Disease Progression? (2017) (94)
Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort (2017) (91)
Caffeine as symptomatic treatment for Parkinson disease (Café-PD) (2017) (89)
Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder. (2016) (88)
Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case–control study (2014) (87)
Comorbidity and medication in REM sleep behavior disorder (2014) (87)
Non-motor outcomes depend on location of neurostimulation in Parkinson's disease. (2019) (82)
Environmental risk factors for REM sleep behavior disorder (2012) (80)
Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study (2015) (78)
Detecting the Cognitive Prodrome of Dementia with Lewy Bodies: A Prospective Study of REM Sleep Behavior Disorder (2017) (75)
Brain perfusion and markers of neurodegeneration in rapid eye movement sleep behavior disorder (2011) (74)
The new definition and diagnostic criteria of Parkinson's disease (2016) (74)
Disease modification and biomarker development in Parkinson disease (2020) (74)
The Montreal Cognitive Assessment: A screening tool for mild cognitive impairment in REM sleep behavior disorder (2010) (73)
Patterns of cortical thinning in idiopathic rapid eye movement sleep behavior disorder (2013) (73)
Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white‐matter alterations (2012) (72)
Cardiac autonomic denervation in Parkinson's disease is linked to REM sleep behavior disorder (2011) (71)
Genome-wide association study in essential tremor identifies three new loci (2016) (70)
Hippocampal perfusion predicts impending neurodegeneration in REM sleep behavior disorder (2012) (69)
Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: the past 10 years. (2013) (66)
Homocysteine and levodopa (2004) (66)
Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts (2017) (66)
Brain perfusion anomalies in rapid eye movement sleep behavior disorder with mild cognitive impairment (2012) (65)
How does dementia with Lewy bodies start? prodromal cognitive changes in REM sleep behavior disorder (2017) (64)
Canadian guideline for Parkinson disease (2019) (64)
Longitudinal assessment of excessive daytime sleepiness in early Parkinson’s disease (2017) (63)
Electroencephalogram slowing in rapid eye movement sleep behavior disorder is associated with mild cognitive impairment. (2013) (62)
Electroencephalogram slowing predicts neurodegeneration in rapid eye movement sleep behavior disorder (2016) (59)
Predicting Parkinson's disease - why, when, and how? (2009) (57)
Idiopathic REM sleep behavior disorder and neurodegenerative risk: To tell or not to tell to the patient? How to minimize the risk? (2017) (57)
Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies (2019) (54)
A clinical-anatomical signature of Parkinson's disease identified with partial least squares and magnetic resonance imaging (2017) (54)
Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism: The Rotterdam Study (2017) (53)
Cortical and subcortical gray matter bases of cognitive deficits in REM sleep behavior disorder (2018) (53)
Substrate‐Bound β‐Amyloid Peptides Inhibit Cell Adhesion and Neurite Outgrowth in Primary Neuronal Cultures (2000) (52)
Family history of idiopathic REM behavior disorder (2013) (49)
Validity of the Mattis Dementia Rating Scale to Detect Mild Cognitive Impairment in Parkinson’s Disease and REM Sleep Behavior Disorder (2011) (49)
Electroencephalographic prodromal markers of dementia across conscious states in Parkinson's disease. (2016) (49)
Comparison between an automatic and a visual scoring method of the chin muscle tone during rapid eye movement sleep. (2014) (47)
White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients (2018) (47)
Trial of Cinpanemab in Early Parkinson's Disease. (2022) (45)
Abolishing the 1‐year rule: How much evidence will be enough? (2016) (45)
Caffeine in Parkinson's disease: A pilot open‐label, dose‐escalation study (2011) (42)
Suggested immobilization test for diagnosis of restless legs syndrome in Parkinson's disease (2012) (42)
Parkinson’s Disease Genetic Loci in Rapid Eye Movement Sleep Behavior Disorder (2015) (41)
Screening for prodromal Parkinson's disease in the general community: a sleep-based approach. (2016) (41)
Prodromal Parkinson's disease--using REM sleep behavior disorder as a window. (2014) (41)
Trial of Prasinezumab in Early-Stage Parkinson's Disease. (2022) (41)
Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease (2021) (41)
Brain cholinergic alterations in idiopathic REM sleep behaviour disorder: a PET imaging study with 18F-FEOBV. (2019) (41)
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial (2021) (40)
Sleep Disturbances in the Prodromal Stage of Parkinson Disease (2017) (40)
Insomnia and somnolence in idiopathic RBD: a prospective cohort study (2017) (39)
Sleep bruxism and oromandibular myoclonus in rapid eye movement sleep behavior disorder: a preliminary report. (2013) (38)
Abnormal Gray Matter Shape, Thickness, and Volume in the Motor Cortico-Subcortical Loop in Idiopathic Rapid Eye Movement Sleep Behavior Disorder: Association with Clinical and Motor Features (2018) (38)
Dementia Predictors in Parkinson Disease: A Validation Study. (2017) (37)
Genetic association study of PINK1 coding polymorphisms in Parkinson's disease (2004) (37)
Fine‐Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies (2020) (36)
Risk factors for possible REM sleep behavior disorder (2019) (33)
Age, Gender, Comorbidity, and the MDS-UPDRS: Results from a Population-Based Study (2016) (33)
Sleep disorders and Parkinson disease; lessons from genetics. (2018) (32)
The New Diagnostic Criteria for Parkinson's Disease. (2017) (32)
Brain atrophy in Parkinson's disease with polysomnography-confirmed REM sleep behavior disorder. (2019) (32)
Parkinson’s Disease Subtypes: Critical Appraisal and Recommendations (2021) (31)
Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder (2018) (31)
Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies (2021) (30)
The dementia-associated APOE ε4 allele is not associated with rapid eye movement sleep behavior disorder (2017) (30)
Cognition and olfaction in Parkinson's disease. (2010) (30)
Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism (2020) (30)
Association between insomnia disorder and cognitive function in middle-aged and older adults: a cross-sectional analysis of the Canadian Longitudinal Study on Aging. (2019) (29)
White Matter Hyperintensities Mediate Impact of Dysautonomia on Cognition in Parkinson's Disease (2020) (29)
Longstanding disease-free survival in idiopathic REM sleep behavior disorder: Is neurodegeneration inevitable? (2018) (29)
Effects of menopause on sleep quality and sleep disorders: Canadian Longitudinal Study on Aging. (2019) (29)
Brain Connectivity Alterations Are Associated with the Development of Dementia in Parkinson's Disease (2016) (27)
REM Sleep Behavior Disorder and Prodromal Neurodegeneration – Where Are We Headed? (2013) (27)
Assessment of a prognostic MRI biomarker in early de novo Parkinson's disease (2019) (25)
The effects of exercise on sleep quality in persons with Parkinson's disease: A systematic review with meta-analysis. (2020) (25)
The Quebec Parkinson Network: A Researcher-Patient Matching Platform and Multimodal Biorepository (2019) (24)
Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis. (2017) (24)
Human Activity Recognition from Sensor-Based Large-Scale Continuous Monitoring of Parkinson’s Disease Patients (2017) (24)
Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: A randomized controlled study (2006) (24)
Predicting severity and prognosis in Parkinson's disease from brain microstructure and connectivity (2019) (23)
Glucocerebrosidase mutations and phenoconversion of REM sleep behavior disorder to parkinsonism and dementia. (2019) (23)
Restless legs syndrome outside the blood-brain barrier--exacerbation by domperidone in Parkinson's disease. (2013) (23)
GBA variants in REM sleep behavior disorder: a multicenter study (2019) (23)
Genetic markers of Restless Legs Syndrome in Parkinson disease. (2015) (22)
Algorithmic Complexity of EEG for Prognosis of Neurodegeneration in Idiopathic Rapid Eye Movement Behavior Disorder (RBD) (2017) (21)
Substrate-bound beta-amyloid peptides inhibit cell adhesion and neurite outgrowth in primary neuronal cultures. (2000) (21)
Potential early markers of Parkinson's disease in idiopathic rapid-eye-movement sleep behaviour disorder (2006) (20)
Risk Factor Profile in Parkinson's Disease Subtype with REM Sleep Behavior Disorder. (2016) (20)
C9orf72 Repeat Expansions in Rapid Eye Movement Sleep Behaviour Disorder (2014) (20)
LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder. (2018) (20)
GBA variants in REM sleep behavior disorder (2020) (19)
Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder (2019) (19)
Observational Study of the Relation between Parkinson's Disease and Sleep Apnea. (2015) (19)
Abnormal occipital event-related potentials in Parkinson's disease with concomitant REM sleep behavior disorder. (2013) (18)
Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases (2021) (18)
Myoclonus as an acute complication of low-dose hydromorphone in multiple system atrophy (2006) (17)
A Prodromal Brain‐Clinical Pattern of Cognition in Synucleinopathies (2020) (17)
Prevalence of Convergence Insufficiency in Parkinson's Disease (2017) (17)
Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson’s disease (2020) (17)
Morbidities in rapid eye movement sleep behavior disorder. (2013) (16)
Cognition in REM sleep behavior disorder - A window into preclinical dementia? (2008) (16)
Resting state MRI: a new marker of prodromal neurodegeneration? (2016) (16)
Risk Factors for Phenoconversion in Rapid Eye Movement Sleep Behavior Disorder (2022) (15)
Multimodal phenotypic axes of Parkinson’s disease (2020) (15)
Prodromal PD: A new nosological entity. (2020) (14)
Office-Based Screening for Dementia in Parkinson Disease: The Montreal Parkinson Risk of Dementia Scale in 4 Longitudinal Cohorts (2018) (14)
Implications of nocturnal symptoms towards the early diagnosis of Parkinson’s disease (2014) (14)
A case–control–family study of idiopathic rapid eye movement sleep behavior disorder (2019) (14)
Prodromal Parkinson disease: do we miss the signs? (2019) (14)
Prodromal Marker Progression in Idiopathic Rapid Eye Movement Sleep Behavior Disorder: Sample Size for Clinical Trials (2019) (13)
Diagnosing multiple system atrophy at the prodromal stage (2020) (13)
The role of the melanoma gene MC1R in Parkinson disease and REM sleep behavior disorder (2016) (13)
Dream enactment behavior: review for the clinician. (2020) (12)
High burden of neurological disease in the older general population: results from the Canadian Longitudinal Study on Aging (2018) (12)
Symmetry of Parkinson's disease and REM sleep: One piece of the puzzle (2011) (12)
Is there seasonal variation in risk of Parkinson's disease? (2007) (11)
Treatment of Restless Legs Syndrome (2013) (11)
Clinical Utility of the Envelope Task in Mild Cognitive Impairment and Dementia (2016) (11)
Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experience (2021) (11)
Prospective memory in idiopathic REM sleep behavior disorder with or without mild cognitive impairment: A preliminary study (2019) (11)
Olfaction in patients with isolated REM sleep behavior disorder who eventually develop multiple system atrophy. (2020) (11)
Domperidone for Hypotension in Parkinson's Disease: A Systematic Review. (2017) (11)
From Prodromal to Overt Parkinson’s Disease: Towards a New Definition in the Year 2040 (2018) (10)
Smartphone-based continuous mobility monitoring of Parkinsons disease patients reveals impacts of ambulatory bout length on gait features (2017) (10)
Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease (2020) (10)
Changes in Regional Cerebral Perfusion Over Time in Idiopathic REM Sleep Behavior Disorder (2020) (10)
The GBA p.Trp378Gly mutation is a probable French‐Canadian founder mutation causing Gaucher disease and synucleinopathies (2018) (10)
Does severity of Parkinson's disease vary according to season? (2005) (10)
Autonomic Sweat Responses in REM Sleep Behavior Disorder and Parkinsonism. (2018) (9)
Prevalence of Convergence Insufficiency-Type Symptomatology in Parkinson’s Disease (2017) (9)
Association of Essential Tremor With Novel Risk Loci (2022) (9)
Cognitive dysfunction in rapid eye movement sleep behavior disorder (2013) (8)
Comprehensive Analysis of Familial Parkinsonism Genes in Rapid‐Eye‐Movement Sleep Behavior Disorder (2020) (8)
Diagnosing REM sleep behavior disorder in Parkinson's disease—can we avoid the polysomnogram? (2014) (8)
Large-Scale Continuous Mobility Monitoring of Parkinson's Disease Patients Using Smartphones (2017) (8)
Autonomic dysfunction in RBD--what can it teach us about disease progression? (2008) (8)
Gray matter substrates of depressive and anxiety symptoms in idiopathic REM sleep behavior disorder. (2019) (8)
REM SLEEP BEHAVIOR DISORDER PREDICTS COGNITIVE IMPAIRMENT IN PARKINSON DISEASE WITHOUT DEMENTIA. Authors' reply (2008) (8)
How specific are non-motor symptoms in the prodrome of Parkinson's disease compared to other movement disorders? (2020) (7)
Orthoptic Treatment of Convergence Insufficiency in Parkinson’s Disease: A Case Series (2017) (7)
Nonmotor Aspects of Parkinson's Disease-How Do They Help Diagnosis? (2017) (7)
Novel Associations of BST1 and LAMP3 With REM Sleep Behavior Disorder (2021) (7)
Predicting neurodegenerative disease in idiopathic rapid eye movement (REM) sleep behavior disorder: Conference proceedings, REM Sleep Behavior Symposium 2011 (2013) (6)
Detecting the Cognitive Prodrome of Dementia in Parkinson's Disease. (2020) (6)
Neurodegeneration in REM sleep behavior disorder (2017) (6)
Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s disease (2022) (6)
Inhibition of neurite outgrowth from chick sympathetic neurons by cholinesterase inhibitors is not mediated by binding to cholinesterases (1999) (6)
Body-first versus brain-first biological subtyping of Parkinson's disease. (2020) (6)
Pareidolias and cognition in isolated REM sleep behavior disorder. (2020) (6)
Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder. (2017) (5)
Antidepressants and REM behavior disorder. (2014) (5)
Voice changes in prodromal Parkinson's disease: Is a new biomarker within earshot? (2016) (5)
Dopa‐responsive dystonia presenting with prominent isolated bilateral resting leg tremor: Evidence for a role of parkin? (2003) (5)
Risk factors for possible REM sleep behavior disorders (2020) (5)
Animal indicators for side-effects of pesticide treatments in oilseed in winter. (1986) (4)
Characterization of Depressive and Anxiety Symptoms in Idiopathic REM Sleep Behavior Disorder. (2021) (4)
Phenoconversion from Possible REM Sleep Behavior to Parkinsonism in the Population‐Based CLSA (2021) (4)
Genome-wide association study of REM sleep behavior disorder identifies novel loci with distinct polygenic and brain expression effects (2021) (4)
Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects (2022) (4)
Brain atrophy in prodromal synucleinopathy is shaped by structural connectivity and gene expression (2021) (4)
Neuroprotective Trials in REM Sleep Behavior Disorder (2022) (4)
From the prodromal stage of multiple sclerosis to disease prevention (2022) (4)
Can Parkinson's Disease Come From the Gut? (2015) (4)
Validating Chronic Disease Ascertainment Algorithms for Use in the Canadian Longitudinal Study on Aging* (2013) (4)
Comprehensive Analysis of Brain Volume in REM Sleep Behavior Disorder with Mild Cognitive Impairment. (2021) (4)
Dreaming in dementia—REM sleep behavior disorder and synucleinopathy (2012) (4)
A comprehensive analysis of dominant and recessive parkinsonism genes in REM sleep behavior disorder (2020) (4)
Transcranial ultrasound and olfaction in REM sleep behavior disorder: testing predictors of Parkinson's disease. (2010) (4)
Long Lag Between Drug‐induced Parkinsonism and Idiopathic Parkinson's Disease in Idiopathic REM Sleep Behavior Disorder (2018) (3)
Algorithmic Complexity of EEG for Prognosis of Neurodegeneration in Idiopathic Rapid Eye Movement Behavior Disorder (RBD) (2018) (3)
Answer to a Commentary on "Tango for treatment of motor and non-motor manifestations in Parkinson's disease: A randomized control study". (2017) (3)
SMPD1 variants do not have a major role in rapid eye movement sleep behavior disorder (2020) (3)
Multimodal phenotypic axes of Parkinson’s disease (2021) (3)
Cognition and the Sleep–Wake Cycle in Parkinson’s Disease (2015) (3)
Evolution of Prodromal Multiple System Atrophy from REM Sleep Behavior Disorder: A Descriptive Study (2022) (3)
Restless Leg Syndrome and Objectively‐Measured Atherosclerosis in the Canadian Longitudinal Study on Aging (2020) (3)
Cautionary optimism: caffeine and Parkinson’s disease risk (2016) (3)
Neuroprotective Trials in REM Sleep Behavior Disorder The Way Forward Becomes Clearer (3)
Telephone visit efficacy for Parkinson’s disease during the COVID-19 pandemic (2021) (3)
Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the CLSA. (2021) (2)
Fine-mapping of SNCA in REM sleep behavior disorder and overt synucleinopathies (2019) (2)
A clinical-anatomical signature of Parkinson’s Disease identified with partial least squares and magnetic resonance imaging (2017) (2)
Rare PSAP Variants and Possible Interaction with GBA in REM Sleep Behavior Disorder. (2021) (2)
Application of machine-learning methods for identification of cognitive markers of dementia in REM sleep behavior disorder (2017) (2)
Large-scale population screening for prodromal PD: a way forward becomes clear. (2016) (2)
Treatment of REM Sleep Behavior Disorder in Parkinson’s Disease (2019) (2)
Corrigendum to “Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group” [Sleep Med 14(8) (2013) 795–806] (2014) (2)
Comparing the Two Prodromal Parkinson's Disease Research Criteria—Lessons for Future Studies (2021) (2)
Rare PSAP variants and possible interaction with GBA in REM sleep behavior disorder (2021) (2)
Rapid eye movement sleep behavior disorder : devising controlled active treatment studies for symptomatic and neuroprotective therapy — a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder (2013) (2)
Dopaminergic Imaging and Prodromal Parkinson Disease: A Key Biomarker Arrives. (2017) (2)
Erratum to: Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case–control study (2014) (2)
The North American Prodromal Synucleinopathy (NAPS) Consortium: Baseline neuropsychological findings in 136 participants (2020) (2)
Diagnosis of Parkinson's disease: Imaging and genetics (2016) (2)
Detecting the cognitive prodrome of dementia with Lewy bodies: A prospective study of REM sleep behavior disorder. (2016) (2)
Criteria for Prodromal Parkinson ’ s Disease (2015) (2)
Self‐Report versus Clinician Examination in Early Parkinson's Disease (2021) (2)
Neurodegeneration in Narcolepsy‐Associated Rapid Eye Movement Sleep Behavior Disorder (2020) (1)
Comment: Epidemiology of dementia with Lewy bodies—The Alzheimer-Parkinson overlap (2013) (1)
Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies. (2023) (1)
Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study. (2023) (1)
GBA Mutations in REM Sleep Behavior Disorder and Parkinson’s Disease (S19.007) (2016) (1)
Higher prevalence of visual symptomatology in individuals with Parkinson’s disease (2015) (1)
NPC1 variants are not associated with Parkinson’s disease, REM-sleep behavior disorder or dementia with Lewy bodies in European cohorts (2020) (1)
Parkinson's disease - how do sleep and dementia interact? (2013) (1)
Addressing knowledge gaps in Parkinson’s disease: a report on the Movement Disorder Society’s Centre-to-Centre initiative to improve Parkinson’s disease services in Lao People’s Democratic Republic (2020) (1)
Exercise and Sleep in Parkinson's Disease (2020) (1)
Bedside pressure-pain threshold algometry to measure abdominal tenderness in childhood appendicitis: A retrospective cohort study (2021) (1)
Cardiovascular Risk Factors and Phenoconversion to Neurodegenerative Synucleinopathies in Idiopathic REM Sleep Behavior Disorder (2022) (1)
Identification of REM Sleep Behavior Disorder by Structural Magnetic Resonance Imaging and Machine Learning (2021) (1)
A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson’s Disease: A Qualitative Study (2021) (1)
0726 MOOD AND SLEEP QUALITY SYMPTOMS ARE NOT LINKED TO MILD COGNITIVE IMPAIRMENT IN RAPID EYE MOVEMENT SLEEP BEHAVIOR DISORDER (2017) (1)
Biomarkers of Neurodegenerative Disease in Idiopathic RBD (2019) (1)
Association of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's Disease (2020) (1)
Dementia with Lewy bodies (2015) (1)
SMPD1 variants do not have a major role in REM sleep behavior disorder (2020) (1)
Color Discrimination and Cognitive Impairment in Idiopathic REM Sleep Behavior Disorder (P05.004) (2012) (1)
Insomnia disorder increases the risk of subjective memory decline in middle-aged and older adults: a longitudinal analysis of the Canadian Longitudinal Study on Aging. (2022) (1)
Autonomic Evaluation in Sleep-Related Movement Disorders (2013) (0)
Placebo: from belief to movement. (2014) (0)
The impact of subjective excessive daytime sleepiness on cognition in parkinson disease (2019) (0)
Novel associations of BST1 and LAMP3 with rapid eye movement sleep behavior disorder (2020) (0)
Epigenetic clock acceleration is linked to earlier onset and phenoconversion age in REM sleep behavior disorder (2023) (0)
Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s disease (2022) (0)
Mediterranean diets and prodromal Parkinson's disease: A causal line, or a confound circle? (2018) (0)
POSTUMA, Ron: Montreal/Canada (2019) (0)
Brain atrophy in REM sleep behavior disorder is shaped by gene expression and structural connectivity (2022) (0)
Subcortical Basis of Cognitive Impairment in Idiopathic Rapid Eye Movement Sleep Behavior Disorder (S17.005) (2018) (0)
Baseline characteristics of the North American prodromal Synucleinopathy cohort (2023) (0)
HIPPOCAMPAL PERFUSION PREDICTS THE EMERGENCE OF NEURODEGENERATIVE DISEASE IN IDIOPATHIC REM SLEEP BEHAVIOR DISORDER (2011) (0)
In Reply. (2020) (0)
[Neurodegenerative disorder in idiopathic REM sleep behaviour disorder]. (2009) (0)
White Matter Hyperintensities and Cognitive Decline in de Novo Parkinson’s Disease Patients (2017) (0)
S26.C Markers of neurodegenerative disorders in patients with so-called idiopathic RBD (2007) (0)
525 A population-based study of phenoconversion to parkinsonism from REM sleep behavior: a Population-based Study in the CLSA (2021) (0)
Effects of menopause on sleep symptoms: Canadian longitudinal study on aging (2019) (0)
Continued Validation of the RBD Symptom Severity Scale (RBDSSS) in Participants of the North American Prodromal Synucleinopathy (NAPS) Consortium (P6-13.004) (2023) (0)
0640 North American Prodromal Synucleinopathy Consortium: Baseline characteristics in 251 patients with REM Sleep Behavior Disorder (2022) (0)
Cortical basis of cognitive impairment in idiopathic REM sleep behavior disorder (2017) (0)
Parkinson’s Disease Genetic Loci in Rapid Eye Movement Sleep Behavior Disorder (2015) (0)
Seasonal variation in risk of Parkinson's disease (2006) (0)
Parkinson's Disease Metabolic Network Predicts Phenoconversion in Patients with Idiopathic REM Sleep Behavior Disorder (S19.004) (2013) (0)
Gray matter volume correlates of depressive and anxiety symptoms in idiopathic REM sleep behavior disorder (2017) (0)
Teaching an Old Drug a New Trick for Dystonia (2021) (0)
Iconography : Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases (2011) (0)
Remote monitoring of progression in early Parkinson's disease: reliability and validity of the Roche PD Mobile Application v2 (2021) (0)
Brain-clinical perfusion patterns may predict conversion subtype in REM sleep behavior disorder (2022) (0)
Prevalence and associated factors for REM sleep behaviour disorder: a nation-wide population-based study of 30,097 Canadian adults (2017) (0)
Neurodegenerative Disease in Idiopathic REM Sleep Behavior Disorder (2013) (0)
Risk of OSA affects reaction time and driving performance more than insomnia in the Canadian Longitudinal Study on Aging (2023) (0)
M-H-077 OCCIPITAL DYSFUNCTION IN PATIENTS WITH PARKINSON'S DISEASE AND REM SLEEP BEHAVIOUR DISORDER: AN EVENT-RELATED POTENTIAL STUDY (2011) (0)
Gender and funding success (2019) (0)
Neurogenic Orthostatic Hypotension is Common in Isolated REM Sleep Behavior Disorder (P6-13.001) (2023) (0)
Author response. (2015) (0)
GBA variants in REM sleep behavior disorder risk and conversion: a multicenter study (2020) (0)
Impaired judgment capacities in idiopathic REM sleep behavior disorder (2017) (0)
Hearing impairment and development of parkinsonism and possible rapid eye movement sleep behaviour disorder: A CLSA prospective population‐based study (2022) (0)
0727 TONIC AND PHASIC CHIN EMG DENSITY IN IDIOPATHIC REM SLEEP BEHAVIOR DISORDER (2017) (0)
Placebo (2014) (0)
Non-Motor Symptoms Questionnaire--French Version (2014) (0)
528 REM Sleep Without Atonia in Idiopathic REM Sleep Behavior Disorder in the North American Prodromal Synucleinopathy Cohort (2021) (0)
Addressing knowledge gaps in Parkinson’s disease: a report on the Movement Disorder Society’s Centre-to-Centre initiative to improve Parkinson’s disease services in Lao People’s Democratic Republic (2020) (0)
Is trauma-associated sleep disorder a sub-form REM sleep behavior disorder? a Canadian longitudinal study on aging cohort study (2019) (0)
Insomnia disorder predicts self-reported cognitive decline in middle-aged and older adults (2022) (0)
Dipyridamole plus aspirin for stroke prevention (2006) (0)
Dipyridamole plus aspirin for stroke prevention (2006) (0)
0635 Validation of a clinical scale for defining RBD severity in participants of the North American Prodromal Synucleinopathy (NAPS) consortium (2022) (0)
524 NAPS (0)
Mitochondrial dysfunction underlies cortical atrophy in prodromal synucleinopathies (2022) (0)
Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder (2019) (0)
Analysis of dominant and recessive parkinsonism genes in REM sleep behavior disorder (2020) (0)
Structural alteration of brain cholinergic systems in a prodromal state of synucleinopathy: The idiopathic REM sleep behaviour disorder (2020) (0)
Insomnia and somnolence in idiopathic RBD: a prospective cohort study (2017) (0)
Restless leg syndrome and cardiovascular and cerebrovascular diseases in the Canadian longitudinal study on aging (2019) (0)
Montreal Parkinson Risk of Dementia Scale (2019) (0)
Challenges in the study of individuals at risk for Parkinson disease. (2023) (0)
Symmetry of Parkinson's Disease and Rapid Eye Movement Sleep: One Piece of the Puzzle (2011) (0)
Development and Validation of a clinical scale for defining RBD severity in participants of the North American Prodromal Synucleinopathy (NAPS) consortium (2022) (0)
Journal Scan Sleep accelerates the improvement in working memory performance Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder (2018) (0)
Chapter 92 – Parkinsonism (2017) (0)
Baseline Characteristics of Participants of the SPARK Trial, a Phase 2 Study of the anti-alpha-synuclein antibody Cinpanemab (BIIB054) in Parkinson’s Disease (1579) (2020) (0)
0723 OLFACTION AND COLOR DISCRIMINATION DYSFUNCTIONS IN RAPID EYE MOVEMENT SLEEP BEHAVIOR DISORDER: ASSOCIATION WITH MILD COGNITIVE IMPAIRMENT (2017) (0)
O.016 REM sleep behavior disorder: can you predict Parkinson's in your dreams? (2009) (0)
Dopamine imaging in prodromal Parkinson disease trials (2020) (0)
MDS Research Criteria for Prodromal Pakrinson's Disease (I1.011) (2016) (0)
Predictors of Neurodegeneration in Idiopathic REM sleep behavior disorder: a multicenter cohort study (CCI.003) (2018) (0)
Reduced Retinal Function In Dark-Adaptation In Lewy Body Disease (2011) (0)
Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease (2021) (0)
REM sleep behavior disorder (2021) (0)
planning for the age of neuroprotection Clinical prediction of Parkinson's disease: (2010) (0)
Exploratory Delayed-Start Analysis Of PASADENA Part 3 52-Week OLE Evaluating Prasinezumab Efficacy On Motor Progression And Complications In Early-Stage PD (S32.005) (2023) (0)
M-H-075 COGNITIVE PERFORMANCE AND MILD COGNITIVE IMPAIRMENT IN REM SLEEP BEHAVIOUR DISORDER (2011) (0)
Remote patient testing with smartphones provides reliable, valid and sensitive measures of motor symptom severity in Parkinson’s disease patients (P3.046) (2018) (0)
Multi‐contrast unbiased MRI template of a Parkinson’s disease population (2022) (0)
Sleep Disorders and RBD: What Would James Parkinson Think? (2017) (0)
The Putative Neuroprotective Effects of Caffeine (2011) (0)
Integrated morphometric, molecular, and clinical characterization of Parkinson's disease pathology (2020) (0)
An MRI Atrophy Biomarker Predicts Global Prognosis in Early De Novo Parkinson’s Disease (2019) (0)
CANADIAN CONSORTIUM ON NEURODEGENERATION IN AGING (CCNA) (2022) (0)
Sleep architecture in Parkinson’s disease with mild cognitive impairment (2017) (0)
Changes in frontal perfusion over time in rem sleep behavior disorder (2019) (0)
Sleep disorders and mortality: a prospective study in the Canadian Longitudinal Study on Aging (2022) (0)
Effects of Season and Daylight Savings Time Shifts on Sleep Symptoms: Canadian Longitudinal Study on Aging. (2023) (0)
M-E-056 SLEEP SLOWWAVES IN PARKINSON'S DISEASE (2011) (0)
Hypersomnolence and cognitive performance in older adults: Cross-sectional analysis of the canadian longitudinal study on aging (2019) (0)
Dementia Risk Prediction in a Longitudinal Geriatric Parkinson’s Disease Cohort: Evaluation and Application of the Montreal Parkinson Risk of Dementia Scale (2023) (0)
Common and rare variants in HFE are not associated with Parkinson's disease in Europeans (2020) (0)
Reply To: Cerebral Vasomotor Reactivity in Parkinson's Disease: A Missing Link between Dysautonomia, White Matter Lesions, and Cognitive Decline? (2020) (0)
A dataset of multi-contrast unbiased average MRI templates of a Parkinsons disease population (2022) (0)
Cortical and subcortical gray matter changes in different prodromal phenotypes of dementia with lewy bodies (2017) (0)
The Clinical Diagnosis of Parkinson's Disease—We Are Getting Better (2023) (0)
Sleep Disorders and Future Diagnosis of Parkinsonism: A Prospective Study Using the Canadian Longitudinal Study on Aging. (2021) (0)
HLA in isolated REM sleep behavior disorder and Lewy body dementia (2023) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ronald B. Postuma?

Ronald B. Postuma is affiliated with the following schools:

McGill University